Text Size
56 studies found for:    Open Studies | "Urticaria"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urticaria"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
Conditions: Chronic Urticaria;   Chronic Idiopathic Urticaria;   Chronic Spontaneous Urticaria
Interventions: Drug: Omalizumab (Xolair);   Drug: Placebo
2 Recruiting Profiling Urticaria for the Identification of Subtypes
Conditions: Non-autoreactive Chronic Spontaneous Urticaria;   Autoimmune Chronic Spontaneous Urticaria;   Autoreactive, Non-autoimmune Chronic Spontaneous Urticaria
Intervention:
3 Unknown † The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Conditions: Chronic Idiopathic Urticaria;   Urticaria
Intervention: Drug: Denosin® and Xyzal®
4 Not yet recruiting The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
Conditions: Urticaria;   Angioedema;   Hives;   Swelling
Intervention: Drug: Vitamin D
5 Recruiting Validation of an Urticaria Control Test
Condition: Chronic Urticaria
Intervention:
6 Recruiting Development of an Urticaria Control Test
Condition: Chronic Urticaria
Intervention:
7 Unknown † Evaluating for Contact Allergies in Patients With Chronic Urticaria
Conditions: Urticaria;   Patch Testing;   Dermatitis;   Allergy;   Contact Sensitization
Intervention: Procedure: Patch Testing
8 Not yet recruiting Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
Condition: Chronic Urticaria
Intervention: Drug: Omalizumab
9 Recruiting Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria
Condition: Solar Urticaria
Intervention: Drug: Intravenous immunoglobulins
10 Recruiting Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Biological: Omalizumab;   Biological: Placebo
11 Recruiting Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Both Drugs Alone in High Doses
Condition: Chronic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Hydroxyzine;   Drug: Levocetirizine plus Hydroxyzine
12 Not yet recruiting Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Chinese Herbal Medicine (CHM);   Drug: Placebo
13 Recruiting Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
14 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
15 Recruiting T Cell Function in Chronic Idiopathic Urticaria
Condition: Chronic Urticaria
Intervention:
16 Unknown † The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema
Conditions: Urticaria;   Angioedema
Intervention: Behavioral: Dietary Therapy
17 Recruiting Efficacy Study of Canakinumab to Treat Urticaria
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Canakinumab;   Drug: Placebo
18 Recruiting Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
Condition: Cold Contact Urticaria
Intervention: Drug: Rupatadine
19 Recruiting Cold Urticaria Treatment With Xolair
Condition: Cold Contact Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo
20 Recruiting Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
Conditions: Diagnosis of Chronic Spontaneous Urticaria (CSU) Refractory to H1-antihistamine Treatment;   Presence of Itch an Hives for More Than 6 Weeks;   UAS7 Score of More Than 14 (Range 0-42);   Patient Has History of Insufficient Response to 4x of the Approved Dose of H1-antihistamines;   CSU Diagnosis for More Than 6 Months;   Angioedema at Least 4x in the Last 6 Months
Interventions: Biological: Omalizumab;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years